Ipsen SA - Company Profile
Powered by 
All the sales intelligence you need on Ipsen SA in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Ipsen SA fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Ipsen SA.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Ipsen SA’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 06 Jun 2023 | Ipsen Enters into Licensing Agreement with Medetia | Licensing Agreement |
Ipsen SA
|
Medetia SAS
|
| 09 Jan 2023 | Ipsen Acquires Albireo for Approximately USD1.15 Billion | Acquisition |
Ipsen SA
|
Albireo Pharma Inc |
| 23 Sep 2022 | Albireo Pharma Inc Enters Phase I Clinical Trial Agreement with Labcorp Drug Development for A-2342 (GDCT0482901) | Contract Service Agreement |
Albireo Pharma Inc
|
Labcorp Drug Development |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer